Insider Transactions in Q2 2021 at Vir Biotechnology, Inc. (VIR)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2021
|
Herbert Virgin EVP, Research & CSO |
SELL
Open market or private sale
|
Direct |
1,375
-1.36%
|
$63,250
$46.63 P/Share
|
|
Jun 29
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,375
+1.34%
|
$1,375
$1.53 P/Share
|
|
Jun 25
2021
|
Steven J. Rice Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
3
-0.02%
|
$150
$50.0 P/Share
|
|
Jun 25
2021
|
Steven J. Rice Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3
+0.02%
|
$36
$12.76 P/Share
|
|
Jun 23
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+7.43%
|
$8,000
$1.53 P/Share
|
|
Jun 22
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
8,348
+24.98%
|
-
|
|
Jun 22
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,000,000
-3.75%
|
-
|
|
Jun 22
2021
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
11,974
+25.0%
|
-
|
|
Jun 22
2021
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
1,000,000
-3.75%
|
-
|
|
Jun 21
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
15,174
-0.46%
|
$698,004
$46.38 P/Share
|
|
Jun 17
2021
|
Robert J More Director |
SELL
Open market or private sale
|
Direct |
11,670
-14.4%
|
$501,810
$43.95 P/Share
|
|
Jun 16
2021
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.38%
|
$215,000
$43.67 P/Share
|
|
Jun 16
2021
|
Phillip Pang EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.19%
|
$25,000
$5.17 P/Share
|
|
Jun 15
2021
|
Herbert Virgin EVP, Research & CSO |
SELL
Open market or private sale
|
Direct |
1,375
-1.48%
|
$61,875
$45.29 P/Share
|
|
Jun 15
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,375
+1.46%
|
$1,375
$1.53 P/Share
|
|
Jun 03
2021
|
Robert J More Director |
SELL
Open market or private sale
|
Direct |
11,670
-12.59%
|
$513,480
$44.56 P/Share
|
|
Jun 02
2021
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.2%
|
$410,000
$41.83 P/Share
|
|
Jun 02
2021
|
Phillip Pang EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.74%
|
$0
$0.86 P/Share
|
|
Jun 01
2021
|
Herbert Virgin EVP, Research & CSO |
SELL
Open market or private sale
|
Direct |
1,375
-1.48%
|
$57,750
$42.51 P/Share
|
|
Jun 01
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,375
+1.46%
|
$1,375
$1.53 P/Share
|
|
May 21
2021
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,374
+0.2%
|
-
|
|
May 21
2021
|
Jeffrey S. Hatfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,374
+50.0%
|
-
|
|
May 21
2021
|
Robert J More Director |
SELL
Grant, award, or other acquisition
|
Direct |
3,374
-3.51%
|
-
|
|
May 21
2021
|
Janet Napolitano Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,374
+50.0%
|
-
|
|
May 21
2021
|
Robert Nelsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,374
+10.99%
|
-
|
|
May 21
2021
|
Dipchand Nishar Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,374
+50.0%
|
-
|
|
May 21
2021
|
Robert J Perez Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,374
+50.0%
|
-
|
|
May 21
2021
|
Saira Ramasastry Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,374
+50.0%
|
-
|
|
May 21
2021
|
Phillip A Sharp Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,374
+3.01%
|
-
|
|
May 21
2021
|
Charles Elliott Sigal Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,374
+50.0%
|
-
|
|
May 20
2021
|
Robert J More Director |
SELL
Open market or private sale
|
Direct |
11,670
-5.89%
|
$513,480
$44.17 P/Share
|
|
May 19
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
15,174
-0.3%
|
$667,656
$44.16 P/Share
|
|
May 19
2021
|
Saira Ramasastry Director |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$430,000
$43.73 P/Share
|
|
May 19
2021
|
Saira Ramasastry Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$120,000
$12.76 P/Share
|
|
May 18
2021
|
Herbert Virgin EVP, Research & CSO |
SELL
Open market or private sale
|
Direct |
1,375
-1.48%
|
$61,875
$45.03 P/Share
|
|
May 18
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,375
+1.46%
|
$1,375
$1.53 P/Share
|
|
May 04
2021
|
Herbert Virgin EVP, Research & CSO |
SELL
Open market or private sale
|
Direct |
1,375
-1.48%
|
$63,250
$46.03 P/Share
|
|
May 04
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,375
+1.46%
|
$1,375
$1.53 P/Share
|
|
Apr 27
2021
|
Herbert Virgin EVP, Research & CSO |
SELL
Open market or private sale
|
Direct |
7,900
-7.93%
|
$387,100
$49.5 P/Share
|
|
Apr 27
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,900
+7.35%
|
$7,900
$1.53 P/Share
|
|
Apr 19
2021
|
Herbert Virgin EVP, Research & CSO |
SELL
Open market or private sale
|
Direct |
2,340
-2.49%
|
$112,320
$48.0 P/Share
|
|
Apr 19
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,340
+2.43%
|
$2,340
$1.53 P/Share
|
|
Apr 16
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+3.68%
|
$3,500
$1.53 P/Share
|
|
Apr 13
2021
|
Herbert Virgin EVP, Research & CSO |
SELL
Open market or private sale
|
Direct |
5,560
-5.93%
|
$239,080
$43.57 P/Share
|
|
Apr 13
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,560
+5.6%
|
$5,560
$1.53 P/Share
|
|
Apr 09
2021
|
Herbert Virgin EVP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+13.7%
|
$14,000
$1.53 P/Share
|
|
Apr 08
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
4,180
+20.02%
|
-
|
|
Apr 08
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-1.84%
|
-
|
|
Apr 08
2021
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
5,989
+20.0%
|
-
|
|
Apr 08
2021
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-1.84%
|
-
|